文献速递血液净化与透析肾移植

1995至2013年美国终末期肾病患者超额死亡率的变化

Changes in Excess Mortality from End Stage Renal Disease in the United States from 1995 to 2013.
PubMed 文献 · Clin J Am Soc Nephrol · 2017-12-14

该研究基于美国肾脏数据系统1995至2013年1,938,148例新发ESRD患者,采用相对生存模型分析发现,校正后相对超额风险每5年增加而下降,范围从0-14岁人群的0.73(95%CI 0.69-0.77)到≥65岁人群的0.88(95%CI 0.88-0.88),即超额死亡风险每5年降低12%-27%。透析和 functioning 肾移植期间均观察到超额死亡率下降,年龄与年份、年份与替代治疗方式的交互作用均P<0.001。

要点

  • 1995-2013年美国ESRD患者超额死亡风险显著下降,每5年降低12%-27%。
  • 超额死亡下降见于所有年龄及透析或功能肾移植期间,最年轻肾移植者相对改善最大。
  • 绝对超额死亡下降在年龄最大者中幅度最大。

核心结论

  • 1995至2013年美国ESRD患者相对于一般人群的全因死亡超额风险显著下降。

研究设计与样本

  • 使用美国肾脏数据系统1995-2013年1,938,148例新发ESRD儿童和成人数据,结合CDC年龄、性别、种族和日历年别的一般人群死亡率,采用时间依赖相对生存模型计算相对超额风险。

主要发现

  • 校正后相对超额风险每5年日历时间增量从0-14岁人群的0.73(95%CI 0.69-0.77)到≥65岁人群的0.88(95%CI 0.88-0.88)。
  • 1995至2013年间任意5年间隔内ESRD相关死亡超额风险降低12%-27%。
  • 所有年龄以及透析治疗和功能肾移植期间均观察到超额死亡率随时间下降(年份与年龄、年份与肾脏替代治疗方式的交互作用均P<0.001)。
  • 相对改善最大见于最年轻的功能肾移植患者,绝对超额死亡下降最大见于年龄最大者。

临床怎么用

  • ESRD患者超额死亡风险随时间改善,提示透析和移植管理进步,但不同年龄和替代治疗方式改善幅度不同。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Individuals with ESRD have a very high risk of death. Although mortality rates have decreased over time in ESRD, it is unknown if improvements merely reflect parallel increases in general population survival. We, therefore, examined changes in the excess risk of all-cause mortality-over and above the risk in the general population-among people treated for ESRD in the United States from 1995 to 2013. We hypothesized that the magnitude of change in the excess risk of death would differ by age and RRT modality. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We used time-dependent relative survival models including data from persons with incident ESRD as recorded in the US Renal Data System and age-, sex-, race-, and calendar year-specific general population mortality rates from the Centers for Disease Control and Prevention. We calculated relative excess risks (analogous to hazard ratios) to examine the association between advancing calendar time and the primary outcome of all-cause mortality. RESULTS: We included 1,938,148 children and adults with incident ESRD from 1995 to 2013. Adjusted relative excess risk per 5-year increment in calendar time ranged from 0.73 (95% confidence interval, 0.69 to 0.77) for 0-14 year olds to 0.88 (95% confidence interval, 0.88 to 0.88) for ≥65 year olds, meaning that the excess risk of ESRD-related death decreased by 12%-27% over any 5-year interval between 1995 and 2013. Decreases in excess mortality over time were observed for all ages and both during treatment with dialysis and during time with a functioning kidney transplant (year by age and year by renal replacement modality interactions were both P<0.001), with the largest relative improvements observed for the youngest persons with a functioning kidney transplant. Absolute decreases in excess ESRD-related mortality were greatest for the oldest persons. CONCLUSIONS: The excess risk of all-cause mortality among people with ESRD, over and above the risk in the general population, decreased significantly between 1995 and 2013 in the United States.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Foster BJ, Mitsnefes MM, Dahhou M, et al. Changes in Excess Mortality from End Stage Renal Disease in the United States from 1995 to 2013. Clin J Am Soc Nephrol. 2017. PMID: 29242373. doi:10.2215/CJN.04330417

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。